In vivo, increased GSK3 activity is an early event in the development of insulin resistance where glycogen synthesis is impaired in type 2 diabetes [25] and inhibition of GSK3 in Zucker diabetic fatty rats leads to an improvement in both insulin action and glucose uptake [26]. Here, INS is linked to Insulin resistance.